Analyst consensus rating
Design Therapeutics Analyst Rating: Strong Buy
Direct answer
Design Therapeutics's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.57.
Forecast evidence checked November 12, 2026.
Get free Design Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.77
- Average price target
- $21.57
- High price target
- $26.00
- Low price target
- $19.00
- Low target gap
- +76.4%
- Target upside
- +100.3%
- High target gap
- +141.4%
- Target range width
- 65%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Design Therapeutics?
Design Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $21.57.
How far are Design Therapeutics's low and high targets from the recorded price?
The low target implies +76.4%, while the high target implies +141.4%.
How many analysts are included in Design Therapeutics's consensus?
The verified consensus includes 7 analysts.
How is Design Therapeutics's target upside or downside calculated?
The average target of $21.57 is divided by the recorded price of $10.77, then one is subtracted to produce +100.3%. This does not guarantee a future return.
When was Design Therapeutics's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.